Lisa Stagi


Drug Safety & Quality Head - Roche



Lisa Stagi acts as a Local Safety Responsible and Italian Health Authority contact for local pharmacovigilance activities and as local GXP Quality group Lead.Coming from previous experience in pharmacovigilance and quality position in other pharmacompanies and from a broad previous consultancy  experience.Coordinator in the SIMeF PV working group, in Italy Passionate in working with colleagues on meaningful projects with positive outcomes for patients and in enhancing a safety culture in the network



Lisa Stagi

Sessions


  • Tuesday - November 23, 2021 - 15:20

    Fireside Chat: Strengthening Risk Evaluation and Mitigation Strategies (REMS)

    • Creating a REMS Industry-Wide Standardized Risk Evaluation and Mitigation Strategy (REMS) Program
    • Global regulatory developments
    • EU GVP XVI revision – what we could expect?
    • REMS for generics
    • Effective tools and strategies to improve REMS effectiveness
    • REMS at the patient-level: improving safety and proper use of medicines
    • Evolving REMS: New opportunities for branded drugs 
    • What have we learned? Next steps toward the future 


 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now